Funded Tech Companies
HAYA Therapeutics
HAYA Therapeutics, operating out of Epalinges, Lausanne Vaud, has financial backing from Eli Lilly and Company, Athos and Alexandria Venture Investments.
Company Overview
Company Name
HAYA Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Route de la Corniche 5B, Batiment Alanine
Epalinges, Lausanne Vaud, 1066
Switzerland
Epalinges, Lausanne Vaud, 1066
Switzerland
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Mission: To identify and develop breakthrough disease-modifying therapeutics with the potential for greater efficacy, safety, and accessibility. We are passionate and dedicated to our mission. We have a unique and differentiated proprietary platform for reprogramming disease driving cell-states. Our platform is powerful and versatile, but through partnerships we believe we can do more and help thousands of patients without a current therapeutic option. Partnering with biopharma companies with a given disease or modality expertise is essential to fulfill our mission. Each disease is a unique universe, and each target may require a different approach.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/8/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samir Ounzain
Company Investors
- Eli Lilly and Company
- Athos
- Alexandria Venture Investments
- Longview International
- Earlybird Venture Capital
- Sofinnova Partners
- LifeLink Ventures
- NanoDimension
- Apollo Health Ventures
- Schroders Capital
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs